Alcoholic liver disease (ALD) is a major cause of liver disease worldwide. In patients with
ALD, an increased level of hepatic inflammasome components was observed, together with …

Alcoholic liver disease (ALD) is caused by chronic excessive alcohol consumption, which
leads to inflammation, oxidative stress, lipid accumulation, liver fibrosis/cirrhosis, and even …

Background Nonalcoholic fatty liver disease (NAFLD) is one of the most common chronic
liver diseases and has become a huge public health issue worldwide. Inhibition of …

Non-alcoholic steatohepatitis (NASH) is a severe pathological stage in non-alcoholic fatty
liver disease (NAFLD) and is generally recognized to be induced by chronic inflammation …

Caffeine elicits protective effects against liver diseases, such as NASH; however, its
mechanism of action involving the pyrin domain-containing-3 (NLRP3) inflammasome …

Chronic tissue injury resulting in fibrosis of multiple organs, responsible for one-third of the
death globally. Liver fibrosis is a common pathway/condition involved in all chronic liver …

Non-alcoholic steatohepatitis (NASH) is a global public health concern that may progress
into fibrosis, cirrhosis, and liver cancer, with limited curative treatment options. While the …

Background and Aims: Activation of the inflammasome NLRP3 (NOD-, LRR-and pyrin
domain containing 3) contributes to the development of non-alcoholic fatty liver disease …

Nonalcoholic steatohepatitis (NASH) is the progressive stage of nonalcoholic fatty liver
disease that may ultimately lead to cirrhosis and liver cancer, and there are few therapeutic …

Alcohol abuse and high-fat diet–induced liver diseases have been the most prevalent
chronic liver diseases and the leading reasons for liver transplantation around the world …